| ANOVA | analysis of variance |
| CA9 | carbonic anhydrase 9 |
| ccRCC | clear cell renal cell carcinoma |
| CDH1 | cadherin 1 (E-cadherin) |
| CDH2 | cadherin 2 (N-cadherin) |
| CI | confidence interval |
| CTNNB1 | catenin beta 1 (β-catenin) |
| DAPI | 4′,6-diamidino-2-phenylindole |
| DFS | disease-free survival |
| EMT | epithelial–mesenchymal transition |
| EMT-TF | EMT-inducing transcription factor |
| FFPE | formalin-fixed, paraffin-embedded |
| GEPIA | Gene Expression Profiling Interactive Analysis |
| GTEx | Genotype-Tissue Expression |
| H&E | hematoxylin and eosin |
| HIF1A | hypoxia-inducible factor 1 subunit alpha |
| HR | hazard ratio |
| KIRC | kidney renal clear cell carcinoma |
| OS | overall survival |
| PBS | phosphate-buffered saline |
| PCDH9 | protocadherin 9 |
| PFA | paraformaldehyde |
| PFI | progression-free interval |
| SD | standard deviation |
| SNAI1 | snail family transcriptional repressor 1 |
| SNAI2 | snail family transcriptional repressor 2 |
| TCGA | The Cancer Genome Atlas |
| TPM | transcripts per million |
| VHL | von Hippel–Lindau |
| VIM | vimentin |
| WHO/ISUP | World Health Organization/International Society of Urological Pathology |
| ZEB1 | zinc finger E-box binding homeobox 1 |
| ZEB2 | zinc finger E-box binding homeobox 2 |